Polio vaccines can be classified into two types: the inactivated polio vaccine (IPV) and oral polio vaccine. Oral polio vaccine is more active than IPV as it has both weakened and live poliovirus. Inactivated polio vaccine is a vaccine prepared from suspension of inactivated (killed) poliovirus strains with formalin. It is an injectable vaccine that can either be given alone or with other vaccines. IPV has the ability to provide serum immunity against all the three types of poliovirus and consequent protection against paralytic poliomyelitis. Rabies virus is transferred to humans through the saliva of an animal who is infected by it. Inactivated rabies virus (IRV) is injected before or after the infection of the virus in 1 ml doses having 2.5 IU per ml of rabies virus antigen.
This report aims to provide a comprehensive presentation of the global market for Inactivated Polio and Rabies Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inactivated Polio and Rabies Vaccines. This report contains market size and forecasts of Inactivated Polio and Rabies Vaccines in global, including the following market information:
Global Inactivated Polio and Rabies Vaccines Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Inactivated Polio and Rabies Vaccines Market Sales, 2018-2023, 2024-2030, (K Dose)
Global top five Inactivated Polio and Rabies Vaccines companies in 2022 (%)
The global Inactivated Polio and Rabies Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Inactivated Polio Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Inactivated Polio and Rabies Vaccines include Bharat Biotech, BIO-MED, Serum Institute of India, Kedrion Biopharma, GlaxoSmithKline, Merck and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inactivated Polio and Rabies Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inactivated Polio and Rabies Vaccines Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Inactivated Polio and Rabies Vaccines Market Segment Percentages, by Type, 2022 (%)
Inactivated Polio Vaccine
Inactivated Rabies Vaccine
Global Inactivated Polio and Rabies Vaccines Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Inactivated Polio and Rabies Vaccines Market Segment Percentages, by Application, 2022 (%)
Pediatrics
Adults
Global Inactivated Polio and Rabies Vaccines Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Dose)
Global Inactivated Polio and Rabies Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inactivated Polio and Rabies Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inactivated Polio and Rabies Vaccines revenues share in global market, 2022 (%)
Key companies Inactivated Polio and Rabies Vaccines sales in global market, 2018-2023 (Estimated), (K Dose)
Key companies Inactivated Polio and Rabies Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bharat Biotech
BIO-MED
Serum Institute of India
Kedrion Biopharma
GlaxoSmithKline
Merck
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inactivated Polio and Rabies Vaccines, market overview.
Chapter 2: Global Inactivated Polio and Rabies Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Inactivated Polio and Rabies Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inactivated Polio and Rabies Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inactivated Polio and Rabies Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Inactivated Polio and Rabies Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Polio and Rabies Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Polio and Rabies Vaccines Overall Market Size
2.1 Global Inactivated Polio and Rabies Vaccines Market Size: 2022 VS 2030
2.2 Global Inactivated Polio and Rabies Vaccines Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Inactivated Polio and Rabies Vaccines Sales: 2018-2030
3 Company Landscape
3.1 Top Inactivated Polio and Rabies Vaccines Players in Global Market
3.2 Top Global Inactivated Polio and Rabies Vaccines Companies Ranked by Revenue
3.3 Global Inactivated Polio and Rabies Vaccines Revenue by Companies
3.4 Global Inactivated Polio and Rabies Vaccines Sales by Companies
3.5 Global Inactivated Polio and Rabies Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inactivated Polio and Rabies Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inactivated Polio and Rabies Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Polio and Rabies Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Polio and Rabies Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Polio and Rabies Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Polio and Rabies Vaccines Market Size Markets, 2022 & 2030
4.1.2 Inactivated Polio Vaccine
4.1.3 Inactivated Rabies Vaccine
4.2 By Type - Global Inactivated Polio and Rabies Vaccines Revenue & Forecasts
4.2.1 By Type - Global Inactivated Polio and Rabies Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Inactivated Polio and Rabies Vaccines Revenue, 2024-2030
4.2.3 By Type - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
4.3 By Type - Global Inactivated Polio and Rabies Vaccines Sales & Forecasts
4.3.1 By Type - Global Inactivated Polio and Rabies Vaccines Sales, 2018-2023
4.3.2 By Type - Global Inactivated Polio and Rabies Vaccines Sales, 2024-2030
4.3.3 By Type - Global Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
4.4 By Type - Global Inactivated Polio and Rabies Vaccines Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Polio and Rabies Vaccines Market Size, 2022 & 2030
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Inactivated Polio and Rabies Vaccines Revenue & Forecasts
5.2.1 By Application - Global Inactivated Polio and Rabies Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Inactivated Polio and Rabies Vaccines Revenue, 2024-2030
5.2.3 By Application - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
5.3 By Application - Global Inactivated Polio and Rabies Vaccines Sales & Forecasts
5.3.1 By Application - Global Inactivated Polio and Rabies Vaccines Sales, 2018-2023
5.3.2 By Application - Global Inactivated Polio and Rabies Vaccines Sales, 2024-2030
5.3.3 By Application - Global Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
5.4 By Application - Global Inactivated Polio and Rabies Vaccines Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Inactivated Polio and Rabies Vaccines Market Size, 2022 & 2030
6.2 By Region - Global Inactivated Polio and Rabies Vaccines Revenue & Forecasts
6.2.1 By Region - Global Inactivated Polio and Rabies Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Inactivated Polio and Rabies Vaccines Revenue, 2024-2030
6.2.3 By Region - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
6.3 By Region - Global Inactivated Polio and Rabies Vaccines Sales & Forecasts
6.3.1 By Region - Global Inactivated Polio and Rabies Vaccines Sales, 2018-2023
6.3.2 By Region - Global Inactivated Polio and Rabies Vaccines Sales, 2024-2030
6.3.3 By Region - Global Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Inactivated Polio and Rabies Vaccines Revenue, 2018-2030
6.4.2 By Country - North America Inactivated Polio and Rabies Vaccines Sales, 2018-2030
6.4.3 US Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.4.4 Canada Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.4.5 Mexico Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Inactivated Polio and Rabies Vaccines Revenue, 2018-2030
6.5.2 By Country - Europe Inactivated Polio and Rabies Vaccines Sales, 2018-2030
6.5.3 Germany Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5.4 France Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5.5 U.K. Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5.6 Italy Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5.7 Russia Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5.8 Nordic Countries Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.5.9 Benelux Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Inactivated Polio and Rabies Vaccines Revenue, 2018-2030
6.6.2 By Region - Asia Inactivated Polio and Rabies Vaccines Sales, 2018-2030
6.6.3 China Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.6.4 Japan Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.6.5 South Korea Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.6.6 Southeast Asia Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.6.7 India Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Inactivated Polio and Rabies Vaccines Revenue, 2018-2030
6.7.2 By Country - South America Inactivated Polio and Rabies Vaccines Sales, 2018-2030
6.7.3 Brazil Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.7.4 Argentina Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Sales, 2018-2030
6.8.3 Turkey Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.8.4 Israel Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.8.5 Saudi Arabia Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
6.8.6 UAE Inactivated Polio and Rabies Vaccines Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Bharat Biotech
7.1.1 Bharat Biotech Company Summary
7.1.2 Bharat Biotech Business Overview
7.1.3 Bharat Biotech Inactivated Polio and Rabies Vaccines Major Product Offerings
7.1.4 Bharat Biotech Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 Bharat Biotech Key News & Latest Developments
7.2 BIO-MED
7.2.1 BIO-MED Company Summary
7.2.2 BIO-MED Business Overview
7.2.3 BIO-MED Inactivated Polio and Rabies Vaccines Major Product Offerings
7.2.4 BIO-MED Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 BIO-MED Key News & Latest Developments
7.3 Serum Institute of India
7.3.1 Serum Institute of India Company Summary
7.3.2 Serum Institute of India Business Overview
7.3.3 Serum Institute of India Inactivated Polio and Rabies Vaccines Major Product Offerings
7.3.4 Serum Institute of India Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Serum Institute of India Key News & Latest Developments
7.4 Kedrion Biopharma
7.4.1 Kedrion Biopharma Company Summary
7.4.2 Kedrion Biopharma Business Overview
7.4.3 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Major Product Offerings
7.4.4 Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Kedrion Biopharma Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Major Product Offerings
7.5.4 GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Merck
7.6.1 Merck Company Summary
7.6.2 Merck Business Overview
7.6.3 Merck Inactivated Polio and Rabies Vaccines Major Product Offerings
7.6.4 Merck Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Merck Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Inactivated Polio and Rabies Vaccines Major Product Offerings
7.7.4 Pfizer Inactivated Polio and Rabies Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
8 Global Inactivated Polio and Rabies Vaccines Production Capacity, Analysis
8.1 Global Inactivated Polio and Rabies Vaccines Production Capacity, 2018-2030
8.2 Inactivated Polio and Rabies Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Polio and Rabies Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Polio and Rabies Vaccines Supply Chain Analysis
10.1 Inactivated Polio and Rabies Vaccines Industry Value Chain
10.2 Inactivated Polio and Rabies Vaccines Upstream Market
10.3 Inactivated Polio and Rabies Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Polio and Rabies Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Inactivated Polio and Rabies Vaccines in Global Market
Table 2. Top Inactivated Polio and Rabies Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Inactivated Polio and Rabies Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Inactivated Polio and Rabies Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Inactivated Polio and Rabies Vaccines Sales by Companies, (K Dose), 2018-2023
Table 6. Global Inactivated Polio and Rabies Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Inactivated Polio and Rabies Vaccines Price (2018-2023) & (US$/Dose)
Table 8. Global Manufacturers Inactivated Polio and Rabies Vaccines Product Type
Table 9. List of Global Tier 1 Inactivated Polio and Rabies Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Polio and Rabies Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Inactivated Polio and Rabies Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Inactivated Polio and Rabies Vaccines Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Inactivated Polio and Rabies Vaccines Sales (K Dose), 2018-2023
Table 15. By Type - Global Inactivated Polio and Rabies Vaccines Sales (K Dose), 2024-2030
Table 16. By Application ? Global Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Inactivated Polio and Rabies Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Inactivated Polio and Rabies Vaccines Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Inactivated Polio and Rabies Vaccines Sales (K Dose), 2018-2023
Table 20. By Application - Global Inactivated Polio and Rabies Vaccines Sales (K Dose), 2024-2030
Table 21. By Region ? Global Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Inactivated Polio and Rabies Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Inactivated Polio and Rabies Vaccines Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Inactivated Polio and Rabies Vaccines Sales (K Dose), 2018-2023
Table 25. By Region - Global Inactivated Polio and Rabies Vaccines Sales (K Dose), 2024-2030
Table 26. By Country - North America Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2018-2023
Table 29. By Country - North America Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2024-2030
Table 30. By Country - Europe Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2018-2023
Table 33. By Country - Europe Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2024-2030
Table 34. By Region - Asia Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2018-2023
Table 37. By Region - Asia Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2024-2030
Table 38. By Country - South America Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2018-2023
Table 41. By Country - South America Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2024-2030
Table 42. By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2018-2023
Table 45. By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Sales, (K Dose), 2024-2030
Table 46. Bharat Biotech Company Summary
Table 47. Bharat Biotech Inactivated Polio and Rabies Vaccines Product Offerings
Table 48. Bharat Biotech Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 49. Bharat Biotech Key News & Latest Developments
Table 50. BIO-MED Company Summary
Table 51. BIO-MED Inactivated Polio and Rabies Vaccines Product Offerings
Table 52. BIO-MED Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 53. BIO-MED Key News & Latest Developments
Table 54. Serum Institute of India Company Summary
Table 55. Serum Institute of India Inactivated Polio and Rabies Vaccines Product Offerings
Table 56. Serum Institute of India Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 57. Serum Institute of India Key News & Latest Developments
Table 58. Kedrion Biopharma Company Summary
Table 59. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Product Offerings
Table 60. Kedrion Biopharma Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 61. Kedrion Biopharma Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Product Offerings
Table 64. GlaxoSmithKline Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Merck Company Summary
Table 67. Merck Inactivated Polio and Rabies Vaccines Product Offerings
Table 68. Merck Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 69. Merck Key News & Latest Developments
Table 70. Pfizer Company Summary
Table 71. Pfizer Inactivated Polio and Rabies Vaccines Product Offerings
Table 72. Pfizer Inactivated Polio and Rabies Vaccines Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 73. Pfizer Key News & Latest Developments
Table 74. Inactivated Polio and Rabies Vaccines Production Capacity (K Dose) of Key Manufacturers in Global Market, 2021-2023 (K Dose)
Table 75. Global Inactivated Polio and Rabies Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 76. Global Inactivated Polio and Rabies Vaccines Production by Region, 2018-2023 (K Dose)
Table 77. Global Inactivated Polio and Rabies Vaccines Production by Region, 2024-2030 (K Dose)
Table 78. Inactivated Polio and Rabies Vaccines Market Opportunities & Trends in Global Market
Table 79. Inactivated Polio and Rabies Vaccines Market Drivers in Global Market
Table 80. Inactivated Polio and Rabies Vaccines Market Restraints in Global Market
Table 81. Inactivated Polio and Rabies Vaccines Raw Materials
Table 82. Inactivated Polio and Rabies Vaccines Raw Materials Suppliers in Global Market
Table 83. Typical Inactivated Polio and Rabies Vaccines Downstream
Table 84. Inactivated Polio and Rabies Vaccines Downstream Clients in Global Market
Table 85. Inactivated Polio and Rabies Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inactivated Polio and Rabies Vaccines Segment by Type in 2022
Figure 2. Inactivated Polio and Rabies Vaccines Segment by Application in 2022
Figure 3. Global Inactivated Polio and Rabies Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inactivated Polio and Rabies Vaccines Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Inactivated Polio and Rabies Vaccines Revenue, 2018-2030 (US$, Mn)
Figure 7. Inactivated Polio and Rabies Vaccines Sales in Global Market: 2018-2030 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Inactivated Polio and Rabies Vaccines Revenue in 2022
Figure 9. By Type - Global Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 11. By Type - Global Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 12. By Type - Global Inactivated Polio and Rabies Vaccines Price (US$/Dose), 2018-2030
Figure 13. By Application - Global Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 15. By Application - Global Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 16. By Application - Global Inactivated Polio and Rabies Vaccines Price (US$/Dose), 2018-2030
Figure 17. By Region - Global Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 20. By Region - Global Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 21. By Country - North America Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 22. By Country - North America Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 23. US Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 28. Germany Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 29. France Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 37. China Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 41. India Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 43. By Country - South America Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 44. Brazil Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Inactivated Polio and Rabies Vaccines Sales Market Share, 2018-2030
Figure 48. Turkey Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Inactivated Polio and Rabies Vaccines Revenue, (US$, Mn), 2018-2030
Figure 52. Global Inactivated Polio and Rabies Vaccines Production Capacity (K Dose), 2018-2030
Figure 53. The Percentage of Production Inactivated Polio and Rabies Vaccines by Region, 2022 VS 2030
Figure 54. Inactivated Polio and Rabies Vaccines Industry Value Chain
Figure 55. Marketing Channels
